Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$240M |
| 2 |
eBay
EBAY
|
+$231M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$216M |
| 4 |
Ameren
AEE
|
+$196M |
| 5 |
Kohl's
KSS
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$552M |
| 2 |
Micron Technology
MU
|
+$425M |
| 3 |
Visa
V
|
+$225M |
| 4 |
Marathon Petroleum
MPC
|
+$225M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$218M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.17% |
| 2 | Healthcare | 12.72% |
| 3 | Technology | 12.27% |
| 4 | Industrials | 11.44% |
| 5 | Consumer Discretionary | 11.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
iShares Floating Rate Bond ETF
FLOT
$10.6B
| $3.49M | ﹤0.01% |
68,471
-4,965
| -7% | -$253K |
|
2002
Kemper
KMPR
$1.67B
| $3.47M | ﹤0.01% |
60,950
+15,656
| +35% | +$961K |
|
|
MSL
2003
DELISTED
Midsouth Bancorp, Inc.
MSL
| $3.47M | ﹤0.01% |
274,199
+43,633
| +19% | +$592K |
|
2004
Maximus
MMS
$3.07B
| $3.46M | ﹤0.01% |
51,876
+34,286
| +195% | +$2.33M |
|
|
TYME
2005
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
| $3.46M | ﹤0.01% |
1,551,315
+1,313,190
| +551% | +$5.36M |
|
|
LKFT
2006
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.93B
| $3.45M | ﹤0.01% |
34,576
-10,828
| -24% | -$1.17M |
|
2007
RCI Hospitality Holdings
RICK
$227M
| $3.43M | ﹤0.01% |
120,826
+64,492
| +114% | +$1.86M |
|
|
PNNT
2008
Pennant Park Investment Corp
PNNT
$249M
| $3.43M | ﹤0.01% |
513,077
+72,748
| +17% | +$504K |
|
2009
Titan International
TWI
$463M
| $3.42M | ﹤0.01% |
+271,509
| New | +$3.53M |
|
2010
Gorman-Rupp
GRC
$2.05B
| $3.42M | ﹤0.01% |
116,920
+64,676
| +124% | +$1.9M |
|
|
AVX
2011
DELISTED
AVX Corporation
AVX
| $3.41M | ﹤0.01% |
206,172
+191,128
| +1,270% | +$3.38M |
|
2012
Blackstone Mortgage Trust
BXMT
$2.36B
| $3.4M | ﹤0.01% |
108,352
-274,747
| -72% | -$8.61M |
|
|
ENV
2013
DELISTED
ENVESTNET, INC.
ENV
| $3.39M | ﹤0.01% |
59,104
-201,050
| -77% | -$11M |
|
2014
iShares Preferred and Income Securities ETF
PFF
$13.1B
| $3.39M | ﹤0.01% |
90,140
-260,232
| -74% | -$9.76M |
|
|
PRGX
2015
DELISTED
PRGX Global, Inc.
PRGX
| $3.38M | ﹤0.01% |
358,118
+257,675
| +257% | +$2.06M |
|
2016
Triumph Financial Inc
TFIN
$1.77B
| $3.38M | ﹤0.01% |
82,115
-185,778
| -69% | -$7.28M |
|
|
CHA
2017
DELISTED
China Telecom Corporation, LTD
CHA
| $3.38M | ﹤0.01% |
75,987
-24,786
| -25% | -$1.14M |
|
|
ONC
2018
CALL
BeOne Medicines Ltd
ONC
$42.5B
| $3.36M | ﹤0.01% |
+20,000
| New | +$2.71M |
|
|
CVRS
2019
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
| $3.35M | ﹤0.01% |
2,444,944
+277,336
| +13% | +$322K |
|
|
CATC
2020
DELISTED
CAMBRIDGE BANCORP
CATC
| $3.35M | ﹤0.01% |
38,382
+30,883
| +412% | +$2.52M |
|
|
EOCC
2021
DELISTED
Enel Generacion Chile S.A.
EOCC
| $3.33M | ﹤0.01% |
139,812
-83,025
| -37% | -$2.32M |
|
|
MLNT
2022
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
| $3.31M | ﹤0.01% |
89,343
+33,560
| +60% | +$2.21M |
|
|
CPRX
2023
DELISTED
Catalyst Pharmaceutical
CPRX
| $3.3M | ﹤0.01% |
1,382,258
-684,622
| -33% | -$2.28M |
|
2024
Ribbon Communications
RBBN
$367M
| $3.3M | ﹤0.01% |
646,661
+468,732
| +263% | +$3.03M |
|
2025
Huron Consulting
HURN
$2.5B
| $3.3M | ﹤0.01% |
86,520
-137,041
| -61% | -$5.39M |
|
Similar funds
Israel Englander's Q1 2018 Portfolio in Review
As of Q1 2018, Israel Englander held 4,417 positions worth $74.9B, up 3.4% from $72.5B the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
Israel Englander deployed $3.29B of net new capital in Q1 2018, opening 664 new positions and adding to 1,466 existing holdings. Its largest new stake was Tiffany & Co.: 1,078,847 shares worth $105M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $552M trimmed.
- Israel Englander's largest Q1 2018 buy was Tiffany & Co.: 1,078,847 shares worth $105M.
- Israel Englander added most to Boston Scientific in Q1 2018, an estimated $240M increase.
- Israel Englander's biggest Q1 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $552M.
- Israel Englander fully exited Equinix in Q1 2018, selling an estimated $152M.
- Israel Englander's ten largest holdings make up 6.3% of its $74.9B portfolio in Q1 2018.
- Israel Englander opened 664 new positions and closed 833 in Q1 2018.
- Israel Englander's portfolio value rose 3.4% quarter-over-quarter to $74.9B.
Based on Millennium Management's 13F filing for Q1 2018, filed 15 May 2018.